We also believe that future studies should better elucidate the specific role of different isoforms of adiponectin in the pathophysiology of NAFLD, as well as the AdipoR1 and AdipoR2 signaling mechanisms involved in the development and progression of NAFLD. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.